TR201909626T4 - Yaralanmış vücut dokusunun iyileştirilmesi promosyonu olarak ektoin veya hidroksiektoin içeren bileşim. - Google Patents
Yaralanmış vücut dokusunun iyileştirilmesi promosyonu olarak ektoin veya hidroksiektoin içeren bileşim. Download PDFInfo
- Publication number
- TR201909626T4 TR201909626T4 TR2019/09626T TR201909626T TR201909626T4 TR 201909626 T4 TR201909626 T4 TR 201909626T4 TR 2019/09626 T TR2019/09626 T TR 2019/09626T TR 201909626 T TR201909626 T TR 201909626T TR 201909626 T4 TR201909626 T4 TR 201909626T4
- Authority
- TR
- Turkey
- Prior art keywords
- hydroxyectoin
- composition containing
- body tissue
- healing
- promoting
- Prior art date
Links
- KIIBBJKLKFTNQO-WHFBIAKZSA-N 5-hydroxyectoine Chemical compound CC1=N[C@H](C(O)=O)[C@@H](O)CN1 KIIBBJKLKFTNQO-WHFBIAKZSA-N 0.000 title abstract 2
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 title abstract 2
- 230000035876 healing Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- NHJUPBDCSOGIKX-QMWFWAMKSA-N 1-O-(D-glucosyl)glycerol Chemical compound OCC(O)COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NHJUPBDCSOGIKX-QMWFWAMKSA-N 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Etken madde olarak ektoin, hidroksiektoin, glukosilgliserol ve / veya tuzları, bu bileşiklerin, yaralı vücut dokusunun geri kazanılmasını desteklemek için bu bileşiklerin esterleri ya da amidlerini içeren bir bileşim Buluş, kronik yaraların veya ülserlerin tedavisinde özellikle önemlidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012013482.7A DE102012013482A1 (de) | 2012-07-09 | 2012-07-09 | Zusammensetzung zur Förderung der Wiederherstellung von verletztem Körpergewebe |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201909626T4 true TR201909626T4 (tr) | 2019-07-22 |
Family
ID=48794047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/09626T TR201909626T4 (tr) | 2012-07-09 | 2013-06-19 | Yaralanmış vücut dokusunun iyileştirilmesi promosyonu olarak ektoin veya hidroksiektoin içeren bileşim. |
Country Status (11)
Country | Link |
---|---|
US (3) | US20150297592A1 (tr) |
EP (3) | EP2869854B1 (tr) |
CN (2) | CN107252427B (tr) |
DE (1) | DE102012013482A1 (tr) |
DK (1) | DK2869854T3 (tr) |
ES (2) | ES2800915T3 (tr) |
HU (1) | HUE044118T2 (tr) |
PL (1) | PL2869854T3 (tr) |
PT (1) | PT2869854T (tr) |
TR (1) | TR201909626T4 (tr) |
WO (1) | WO2014009118A1 (tr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3120841A1 (de) * | 2015-07-23 | 2017-01-25 | Christophe Sivanzire | Pharmazeutisches präparat |
DE102015121050A1 (de) * | 2015-12-03 | 2017-06-08 | Bitop Ag | Kompatibles Solut oder Solutgemisch zur Verwendung bei der Prävention oder Behandlung von Krankheiten mit Barrieredefekten in Epithelgeweben |
DE102016111882A1 (de) * | 2016-06-29 | 2018-01-04 | Bitop Ag | Zusammensetzung zur Bekämpfung von gastroösophagealen Refluxerkrankungen |
TWI629265B (zh) * | 2017-04-13 | 2018-07-11 | 元智大學 | Reactive raw humectant and its preparation |
US10543158B2 (en) | 2017-04-17 | 2020-01-28 | W Skincare, LLC | Autophagy activating complex, compositions and methods |
CN107375996B (zh) * | 2017-07-31 | 2018-09-21 | 长沙海润生物技术有限公司 | 一种生物功能性敷料及其制备方法 |
CN107496661A (zh) * | 2017-09-11 | 2017-12-22 | 南京华开生物科技有限公司 | 硅酮疤痕凝胶及其制备方法 |
JP6315533B1 (ja) * | 2018-02-01 | 2018-04-25 | 株式会社ノエビア | 皮膚外用剤 |
CN110732802A (zh) * | 2018-10-22 | 2020-01-31 | 嘉兴学院 | 细间距焊盘键合用缓蚀助焊剂及其制备方法 |
CN109731123A (zh) * | 2019-02-25 | 2019-05-10 | 湖南博隽生物医药有限公司 | 一种医学护理用抗感染材料及其制备方法 |
TWI723482B (zh) * | 2019-07-31 | 2021-04-01 | 嘉會生技股份有限公司 | 促進富含血小板血漿釋放生長因子之方法 |
CN110575403A (zh) * | 2019-10-25 | 2019-12-17 | 深圳市阳光优品科技有限公司 | 一种可减少防晒乳中的化学防晒剂添加量的制备方法 |
CN110859775A (zh) * | 2019-12-03 | 2020-03-06 | 中国科学院青岛生物能源与过程研究所 | 甘油葡萄糖苷在透皮吸收组合物中的应用 |
CN111172127A (zh) * | 2020-01-17 | 2020-05-19 | 浙江工业大学 | 一种蔗糖磷酸化酶在制备甘油葡萄糖苷中的应用 |
CN111773222A (zh) * | 2020-08-10 | 2020-10-16 | 华熙生物科技股份有限公司 | 四氢嘧啶和/或羟基四氢嘧啶在制备治疗烧烫伤药物中的应用 |
CN112107720A (zh) * | 2020-09-18 | 2020-12-22 | 华熙生物科技股份有限公司 | 透气性好的医用压敏胶及依克多因在提高医用压敏胶透气性中的应用 |
CN115192602B (zh) * | 2021-04-14 | 2024-02-02 | 华熙生物科技股份有限公司 | 一种复合益生元及其在调节肠道功能中的应用 |
GR20220100433A (el) * | 2022-05-24 | 2023-12-11 | Θεοδοσιος Ιωαννη Λαζαρελης | Φυσικο προϊον για την υγεια της περι-πρωκτικης περιοχης |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19540749A1 (de) | 1995-11-02 | 1997-05-07 | Beiersdorf Ag | Kosmetische Zubereitungen mit einem wirksamen Gehalt an Glycosylglyceriden |
US6242010B1 (en) * | 1999-07-21 | 2001-06-05 | Thione International, Inc. | Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions |
DE10006578C2 (de) | 2000-02-14 | 2002-10-31 | Bitop Ag | Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren |
ITMI20020404A1 (it) * | 2002-02-28 | 2003-08-28 | Ist Naz Stud Cura Dei Tumori | Nuova manganese superossido dismutasi umana |
DE10317400B4 (de) | 2003-04-15 | 2006-04-13 | Universitätsklinikum Hamburg-Eppendorf | EX-VIVO-Hautorganmodell aus Schweinehaut |
JP2004331579A (ja) * | 2003-05-08 | 2004-11-25 | Noevir Co Ltd | 真皮マトリックス産生促進剤 |
DE10330243A1 (de) | 2003-07-03 | 2005-01-20 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis |
AT504347B8 (de) * | 2006-09-21 | 2008-09-15 | Univ Graz Tech | Verfahren zur herstellung von glucosederivaten |
DE102006056766A1 (de) | 2006-12-01 | 2008-06-05 | Bitop Ag | Verwendung von kompatiblen Soluten |
DE102007052380A1 (de) * | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten |
DE102008039231A1 (de) | 2008-08-22 | 2010-02-25 | Bitop Ag | Verwendung von Glucosylglycerol |
DE102008053549A1 (de) * | 2008-10-28 | 2010-04-29 | Bitop Ag | Glucosylglycerol enthaltende Zusammensetzung |
JP2009161564A (ja) * | 2009-04-23 | 2009-07-23 | Tokiwa Yakuhin Kogyo Kk | アトピー性皮膚炎治療用組成物 |
WO2011141611A1 (es) * | 2010-05-14 | 2011-11-17 | Sanidad Y Residencias 21, S.A., | Composiciones de oleuropeína para cicatrización de heridas y úlceras en ancianos y/o diabéticos |
CN102247374B (zh) * | 2011-04-22 | 2013-05-22 | 山东弘立医学动物实验研究有限公司 | 含有四氢嘧啶及其衍生物的治疗皮肤创伤的药物 |
CN102357097A (zh) * | 2011-09-01 | 2012-02-22 | 朱道辰 | 一种预防和治疗皮肤冻伤的药物 |
-
2012
- 2012-07-09 DE DE102012013482.7A patent/DE102012013482A1/de not_active Withdrawn
-
2013
- 2013-06-19 CN CN201710365047.1A patent/CN107252427B/zh active Active
- 2013-06-19 ES ES16196808T patent/ES2800915T3/es active Active
- 2013-06-19 CN CN201380041224.0A patent/CN104540532A/zh active Pending
- 2013-06-19 TR TR2019/09626T patent/TR201909626T4/tr unknown
- 2013-06-19 PT PT13737554T patent/PT2869854T/pt unknown
- 2013-06-19 WO PCT/EP2013/062708 patent/WO2014009118A1/de active Application Filing
- 2013-06-19 EP EP13737554.9A patent/EP2869854B1/de active Active
- 2013-06-19 US US14/413,061 patent/US20150297592A1/en not_active Abandoned
- 2013-06-19 PL PL13737554T patent/PL2869854T3/pl unknown
- 2013-06-19 DK DK13737554.9T patent/DK2869854T3/da active
- 2013-06-19 ES ES13737554T patent/ES2734252T3/es active Active
- 2013-06-19 EP EP19165150.4A patent/EP3536351A1/de not_active Withdrawn
- 2013-06-19 EP EP16196808.6A patent/EP3153185B1/de active Active
- 2013-06-19 HU HUE13737554 patent/HUE044118T2/hu unknown
-
2017
- 2017-03-24 US US15/469,055 patent/US20170189435A1/en not_active Abandoned
-
2021
- 2021-03-31 US US17/218,814 patent/US20210213039A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3153185A1 (de) | 2017-04-12 |
HUE044118T2 (hu) | 2019-10-28 |
DK2869854T3 (da) | 2019-07-22 |
DE102012013482A1 (de) | 2014-01-09 |
PL2869854T3 (pl) | 2019-09-30 |
CN107252427A (zh) | 2017-10-17 |
CN104540532A (zh) | 2015-04-22 |
US20170189435A1 (en) | 2017-07-06 |
EP2869854B1 (de) | 2019-04-10 |
EP2869854A1 (de) | 2015-05-13 |
US20210213039A1 (en) | 2021-07-15 |
PT2869854T (pt) | 2019-07-15 |
EP3153185B1 (de) | 2020-03-25 |
ES2734252T3 (es) | 2019-12-05 |
WO2014009118A1 (de) | 2014-01-16 |
US20150297592A1 (en) | 2015-10-22 |
EP3536351A1 (de) | 2019-09-11 |
CN107252427B (zh) | 2021-11-26 |
ES2800915T3 (es) | 2021-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201909626T4 (tr) | Yaralanmış vücut dokusunun iyileştirilmesi promosyonu olarak ektoin veya hidroksiektoin içeren bileşim. | |
EA201300211A1 (ru) | N-ацилсульфонамидные промоторы апоптоза | |
EA201590661A1 (ru) | Азахиназолиновые ингибиторы атипичной протеинкиназы c | |
MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
EA201590457A1 (ru) | Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b | |
TR201904614T4 (tr) | Novel pyrazole derivative. | |
EA201591727A1 (ru) | Соединения биариламида в качестве ингибиторов киназы | |
BR112016014410A2 (pt) | terapia de combinação com vacina de neoantígeno | |
IN2015MN00478A (tr) | ||
EA202090860A1 (ru) | Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn | |
EA201690754A1 (ru) | Применение ингибитора pcsk9 для лечения гиперлипидемии | |
UA109010C2 (en) | MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY | |
EA201200176A1 (ru) | Производные оксазина и их применение для лечения неврологических нарушений | |
EA201390198A1 (ru) | Гетероциклическое соединение | |
EA201590748A1 (ru) | Противовирусные соединения против rsv | |
MY185103A (en) | Bezylamine derivatives as inhibitors of plasma kallikrein | |
EA201590703A1 (ru) | Ингибиторы mek при лечении вирусных заболеваний | |
EA201690872A2 (ru) | Противовирусная терапия | |
BR112013031402A2 (pt) | derivados de hidantoína como inibidores de kv3 | |
BR112015019412A8 (pt) | inibidores de bace1, seus usos, e composição farmacêutica | |
EA201590364A1 (ru) | Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда | |
EA201591996A1 (ru) | Способы и композиции для заживления раны | |
BR112014028813A2 (pt) | 5-amino[1,4]tiazinas como inibidores bace1 | |
EA201270728A1 (ru) | Пуриновые соединения | |
TR201004464A2 (tr) | Kemik erimesi için formülasyon. |